Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
109,241,884
-
Share change
-
+7,291,872
-
Total reported value
-
$663,112,026
-
Put/Call ratio
-
9.8%
-
Price per share
-
$6.07
-
Number of holders
-
151
-
Value change
-
+$52,701,039
-
Number of buys
-
81
-
Number of sells
-
67
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2023
As of 31 Dec 2023,
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
109,241,884 shares.
The largest 10 holders included
Fosun International Ltd, VANGUARD GROUP INC, TPG GP A, LLC, BlackRock Inc., Rubric Capital Management LP, CITADEL ADVISORS LLC, NEUBERGER BERMAN GROUP LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
151
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.